New5-lipoxygenase inhibitors, designated epocarbazolins A and B, were isolated from the culture broth of Streptomyces anulatus T688-8. These compoundsshowedpotent rat 5-lipoxygenase inhibitory activity with weak antibacterial activity. Structural studies revealed that epocarbazolins are new carbazole antibiotics having a novel substitution pattern and an epoxide in the side chain.
New5-lipoxygenase inhibitors, designated epocarbazolins A and B, were isolated from the culture broth of Streptomyces anulatus T688-8. These compoundsshowedpotent rat 5-lipoxygenase inhibitory activity with weak antibacterial activity. Structural studies revealed that epocarbazolins are new carbazole antibiotics having a novel substitution pattern and an epoxide in the side chain.
It is widely known that arachidonic acid-metabolites products, particularly the arachidonate 5-lipoxygenase (5-LPO) metabolites, are observed as chemical mediators in certain inflammatory and allergic states. Moreover, arachidonic acid and its oxidation products were found in psoriatic skin at increased concentrations.1* Accordingly, 5-LPO inhibitors which block the production of such chemical mediators are expected to be useful for the therapeutic treatment of allergies and inflammations such as asthma, psoriasis and hypersensitivity.
In the course of screening for 5-LPO inhibitors using RBL-1 enzyme, an actinomycete strain identified as Streptomyces anulatus T688-8 was found to produce novel 5-LPO inhibitors, designated epocarbazolins A and B.
In this paper, we describe the taxonomy of the producing organism, fermentation, isolation, structure and biological activities of epocarbazolins A and B. 0.2%, fish meal D30X (Banyu Nutrient) 0.5% and CaCO3 0.3%, the pH being adjusted to 7.0 before sterilization. Shake cultivation was carried out at 28°C for 4 days on a rotary shaker (200rpm). The seed culture (5 ml) was transferred into 500-ml Erlenmeyer flasks containing 100ml of production medium consisting of lactose 1%, dextrin 3%, linseed meal 2%, CaSO4 0.6% and CaCO3 0.5%, the pH being adjusted to 7.0 before autoclaving. The fermentation was carried out for 1 12hours at 28°C and 200rpm on a rotary shaker. Isolation
The fermented broth (18 liters) was separated into the mycelial cake and the supernate by filtration. The mycelial cake was extracted twice with methanol (each 4.5 liters) and the methanolic extract was evaporated to give an aqueous solution. The solution was extracted three times with ethyl acetate (each 600ml) and the extracts were concentrated to dryness in vacuo to yield a crude solid (7.0g). This solid was applied onto a silica gel column (BW-820MH,Fuji Division Chemical Co., Ltd., 200ml) which was washed with a mixture of dichloromethane-methanol (50 : 1, 3 liters) and then eluted with a mixture of dichloromethane -methanol (4 : 1, 1 liter). Active fractions were examined by inhibitory activity against 5-LPOand/or HPLC analysis. The active eluate fractions were evaporated to dryness and the residue was charged on a reversed-phase C18 column (YMC-ODS, AMtype, YMCCo., Ltd., 200ml) and developed with a mixture of acetonitrile -water (1 : 1, v/v). Active fractions (20 ml each) containing epocarbazolin A (Nos. 21~30) or B (Nos. 37~45) were pooled and combined each. Evaporation of the solvent yielded 44.5mg of epocarbazolin A and 52.5mg of epocarbazolin B, respectively. These compounds were photo-labile and all the operations were performed in the dark. Could not be determined accurately because of their photo-unstability. Structure Elucidation The characteristic UVspectra of epocarbazolins were closely related to that of carbazomycin A, indicating that they share a carbazole nucleus as the chromophore. The 13C NMR spectrum of epocarbazolin B revealed the presence of twelve sp2 hybridized carbons which are assignable to the the remaining substituent groups consisting of one hydroxymethyl, one methyl, two hydroxy groups and the alkyl side chain as shown in Fig. 4 . The structure of this side chain was determined as follows. Thê^H COSYspectra revealed the presence of an 3-methyl-pentyl chain moiety (C-13~C-20). The 1H-13C long range couplings were observed between the end of this alkyl chain 13-H and C-10, C-ll, C-12; 12-H and C-10, C-ll, C-13; 10-H and C-ll, C-13. The presence of an epoxide ring was substantiated by the chemical shifts of C-10 and C-ll (3C 64.7 and 63.8, respectively) and the C-H coupling constant of C-10 and 10-H (/=175Hz).
The position of each substituents on the carbazole nucleus was clarified by NMRspectral analyses of 7V,0-tetramethylepocarbazolin B which was prepared by permethylation of epocarbazolin B with Mel in the presence of NaHin DMF.9) In benzene-d6, this compound existed as a mixture of unseparable conformers at a ratio of about 3 : 2, but, their proton and carbon signals were clearly assigned with the aid of the 2D NMRtechniques. In the NOESYspectrum, crosspeaks were observed between 3-OCH3 and 4-H, 4-H and 18-H, 18-H and 6-H, 7-H and 8-OCH3 and 10-H and 17-CH3, establishing the position of five substituents as shownin Fig. 5 . All the proton and carbon signals were unambiguously assigned by the XH-13C COSYand^-^C long range COSYexperiments (Tables 5 and 6 ).^-^C long range correlations (Fig. 5) , which also supported the proposed structure.
Epocarbazolin A showed very similar properties to epocarbazolin B, but it differed in the lack of A had a 2-methyl-butyl group in its side chain instead of the 3-methyl-pentyl group in epocarbazolin B. These differences also supported by the molecular formulae of epocarbazolins A and B. Thus the structures of epocarbazolins A and B have been determined as shown in Fig. 6 . JAN. 1993 Antimicrobial Activity The antimicrobial spectra of epocarbazolins A and B were determined in vitro by the standard agar dilution method employing nutrient agar medium (Eiken, pH 7.0). MICswere expressed in /xg/ml after overnight incubation at 32°C. The antimicrobial activities of epocarbazolins A and B are summarized in Table 7 . Both compounds show moderate activity against Gram-positive bacteria but are inactive against the Gram-negative bacteria tested.
5-LPO Inhibitory
Activity The inhibitory activity against 5-LPO was evaluated by the method of D. J. Hook et al.,10) which comparatively determined the amountsof 5-hydroxy-eicosatetraenoic acid (5-HETE) produced in the enzymesolution containing arachidonic acid, ATP,calcium chloride and glutathione in the presence and absence of inhibitor.
The 5-LPO inhibitory activities of epocarbazolins A and B and tetramethylepocarbazolin B are comparable to that of the known 5-LPOinhibitor carbazomycin B as shown in Table 8 .
Discussion
The structure studies have showedthat epocarbazolins Aand B are newmembersof the carbazole group of antibiotics. Amongthe carbazole antibiotics, epocarbazolins A and B are the first carbazole derivatives having the epoxide ring in their molecule, and their 5,8-substituted carbazole nucleus is also very unique.
Epocarbazolins A and B show potent 5-LPO inhibitory activity. Since tetfamethylepocarbazolin B has no inhibitory activity against 5-LPO, the presence of a free phenolic hydroxy group seems to be essential for 5-LPO inhibitory activity. Recently some carbazole antibiotics such as carazostatin, neocarazostatin and antiostatin bearing the free phenolic hydroxy group have been reported as free radical scavenger9'1 1} or antioxidative agent.12) Thus, the 5-LPO inhibitory activity of epocarbazolins are probably due to radical scavenger activity.
Experimental

General
The IR and UV spectra were determined on a JASCO IR-810 and a UVIDEC-610Cspectrometer, respectively.
The 1H and 13C NMRspectra were recorded on a JEOL JMN-GX400.MS spectra were obtained with a JEOL JMS-AX505Hmass spectrometer.
5-LPO Inhibitory
Activity10) RBL-1 cells were grown for 5 days at 37°C and 5% CO2 in RPMI1640 with 20% heat-inactivated calf serum. After harvested by centrifugation and washed twice with Dulbecco's phosphate-buffered saline without calcium and magnesium (PBS(-)) containing 1 mMEDTA,the cells were sonicated in the same buffer. The suspension was centrifuged at 13,000 x g and the supernatant was stored at -70°C as enzymesolution. Enzymeassays were conducted by diluting the enzyme solution to desired specific activity with PBS(-) containing 28.5mM phosphate, 1 mMEDTA, 0.9mM ATP and 0.9mM glutathione. The enzyme dilution (110^1) was preincubated at 37°C for 5minutes, and then mixed with a test sample in 20/A of 10% DMSO-PBS(-)in the microplate. The reaction was started by addition of 5^1 of substrate (2mMarachidonic acid plus 25 mMcalcium chloride in ethanol -water (3 : 1)). After incubation for 5minutes the reaction was terminated by addition of 135^1 of ethanol and the solution was Methylation of Epocarbazolin B To a mixture of NaH (450mg of 60% oil suspension) and DMF(10ml), epocarbazolin B (120mg) and CH3I (200/A) were added and stirred for 2hours at room temperature. The reaction mixture was poured into water (100 ml) and the A^O-methylated product was extracted with ethyl acetate. The solvent extract wasconcentrated to dryness in vacuo and the residue was subjected to reversed phase silica gel column chromatography. Development with acetonitrile -water (9 : 1 , v/v) gave tetramethylepocarbazolin B (55.9mg).
FAB-MS (positive): m/z 439 (M+); IR (KBr) 2930, 1610, 1460, 1420, 1235, 1090cm"1.
